Gofen & Glossberg’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,764
| Closed | -$314K | – | 581 |
|
|
2022
Q2 | $314K | Sell |
5,764
-214
| -4% | -$11.8K | 0.01% | 409 |
|
|
2022
Q1 | $325K | Sell |
5,978
-1,124
| -16% | -$61.1K | 0.01% | 422 |
|
|
2021
Q4 | $391K | Sell |
7,102
-1,330
| -16% | -$69.2K | 0.01% | 400 |
|
|
2021
Q3 | $403K | Buy |
8,432
+163
| +2% | +$8.19K | 0.01% | 383 |
|
|
2021
Q2 | $412K | Sell |
8,269
-400
| -5% | -$19.2K | 0.01% | 375 |
|
|
2021
Q1 | $387K | Sell |
8,669
-404
| -4% | -$18.3K | 0.01% | 370 |
|
|
2020
Q4 | $417K | Sell |
9,073
-6,869
| -43% | -$316K | 0.01% | 334 |
|
|
2020
Q3 | $750K | Sell |
15,942
-3,435
| -18% | -$172K | 0.02% | 246 |
|
|
2020
Q2 | $988K | Sell |
19,377
-785
| -4% | -$40.3K | 0.03% | 205 |
|
|
2020
Q1 | $955K | Sell |
20,162
-2,044
| -9% | -$109K | 0.04% | 197 |
|
|
2019
Q4 | $1.3M | Sell |
22,206
-120
| -0.5% | -$6.67K | 0.04% | 193 |
|
|
2019
Q3 | $1.19M | Buy |
22,326
+208
| +0.9% | +$10.7K | 0.04% | 197 |
|
|
2019
Q2 | $1.11M | Sell |
22,118
-1,229
| -5% | -$61.7K | 0.04% | 203 |
|
|
2019
Q1 | $1.22M | Sell |
23,347
-1,014
| -4% | -$50.7K | 0.04% | 194 |
|
|
2018
Q4 | $1.16M | Sell |
24,361
-594
| -2% | -$29.3K | 0.05% | 183 |
|
|
2018
Q3 | $1.25M | Buy |
24,955
+1,568
| +7% | +$79.7K | 0.04% | 195 |
|
|
2018
Q2 | $1.18M | Sell |
23,387
-1,039
| -4% | -$52.3K | 0.04% | 195 |
|
|
2018
Q1 | $1.19M | Sell |
24,426
-10,544
| -30% | -$491K | 0.04% | 194 |
|
|
2017
Q4 | $1.55M | Sell |
34,970
-3,232
| -8% | -$149K | 0.06% | 186 |
|
|
2017
Q3 | $1.94M | Sell |
38,202
-360
| -0.9% | -$18.3K | 0.07% | 171 |
|
|
2017
Q2 | $2.08M | Sell |
38,562
-1,132
| -3% | -$60.3K | 0.08% | 166 |
|
|
2017
Q1 | $2.09M | Sell |
39,694
-965
| -2% | -$49K | 0.08% | 161 |
|
|
2016
Q4 | $1.96M | Sell |
40,659
-3,734
| -8% | -$184K | 0.08% | 161 |
|
|
2016
Q3 | $2.39M | Sell |
44,393
-2,427
| -5% | -$133K | 0.1% | 153 |
|
|
2016
Q2 | $2.54M | Sell |
46,820
-5,921
| -11% | -$312K | 0.11% | 144 |
|
|
2016
Q1 | $2.67M | Sell |
52,741
-2,793
| -5% | -$139K | 0.11% | 138 |
|
|
2015
Q4 | $2.8M | Sell |
55,534
-21,298
| -28% | -$1.09M | 0.12% | 133 |
|
|
2015
Q3 | $3.69M | Sell |
76,832
-12,074
| -14% | -$629K | 0.17% | 116 |
|
|
2015
Q2 | $4.63M | Sell |
88,906
-473
| -0.5% | -$26.6K | 0.2% | 109 |
|
|
2015
Q1 | $5.16M | Sell |
89,379
-1,722
| -2% | -$98.7K | 0.22% | 102 |
|
|
2014
Q4 | $4.87M | Sell |
91,101
-8,629
| -9% | -$483K | 0.21% | 106 |
|
|
2014
Q3 | $5.73M | Buy |
99,730
+1,140
| +1% | +$69.9K | 0.25% | 95 |
|
|
2014
Q2 | $6.59M | Buy |
98,590
+494
| +0.5% | +$33.4K | 0.29% | 87 |
|
|
2014
Q1 | $6.86M | Buy |
98,096
+6,484
| +7% | +$438K | 0.32% | 82 |
|
|
2013
Q4 | $6.11M | Buy |
91,612
+1,082
| +1% | +$70.2K | 0.29% | 86 |
|
|
2013
Q3 | $5.68M | Sell |
90,530
-77
| -0.1% | -$4.96K | 0.29% | 87 |
|
|
2013
Q2 | $5.66M | Buy |
+90,607
| New | +$5.75M | 0.31% | 87 |
|
Other funds holding GSK
Gofen & Glossberg's GSK Position: Q3 2022 in Review
Gofen & Glossberg sold out of GSK (GSK) in Q3 2022, closing a stake of 5,764 shares — an estimated $314K sold.
Gofen & Glossberg first reported a position in GSK in Q2 2013 and held it in 37 quarters. The position peaked at $6.86M in Q1 2014. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Gofen & Glossberg reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Gofen & Glossberg sold 5,764 GSK shares in Q3 2022, an estimated $314K.
- Gofen & Glossberg first reported a position in GSK in Q2 2013 and held it in 37 quarters.
- Gofen & Glossberg's GSK position peaked at $6.86M in Q1 2014.
- 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Gofen & Glossberg's 13F filing for Q3 2022, filed 13 Oct 2022.